Marker <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. Changes Independent Auditor to CBIZ CPAs Amid Going Concern Warning
Marker Therapeutics Inc. recently announced a change in its certifying accountant. The transition comes after CBIZ CPAs P.C. acquired the attest business of Marcum LLP, effective November 1, 2024. Marcum continued as Marker Therapeutics' independent registered public accounting firm until August 6, 2025, when it resigned. Subsequently, CBIZ CPAs was appointed as the new independent registered public accounting firm, effective with the review of the company's financial statements for the quarter ending June 30, 2025. This engagement was approved by Marker Therapeutics' Board of Directors. Despite the change, Marcum's reports on the company's financial statements for 2023 and 2024 did not contain any adverse opinions but did include an explanatory paragraph on the company's ability to continue as a going concern.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marker Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-076834), on August 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.